Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page now shows revision v3.6.4, replacing the previous revision v3.6.3, indicating an updated page version.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedLahey Hospital and Medical Center was removed on 2026-06-12 and two Lahey Clinic locations were added on 2026-07-01 and 2026-07-02, reflecting an update to the study's site listings.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a publication citation about immunotherapy in endometrial cancer and updated the page revision to v3.6.3, replacing the previous v3.6.0.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page now states that recruitment has ended ('No longer looking for participants') and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) for visitors. The Sarasota, Florida site entry was updated, changing the listed ZIP from 34236 to 34239 and reflecting an updated enrollment location.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page shows a new revision label, updating from v3.5.4 to v3.5.5, indicating a newer version of the study documentation. This appears to be a maintenance update rather than a change to study details or results.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new version of the page content. This update reflects a minor revision to the page's documentation rather than changes to study data or eligibility criteria.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.